A commonly occurring genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster is associated with the risk of strabismus by Plotnikov, D et al.
Vol.:(0123456789) 
Human Genetics 
https://doi.org/10.1007/s00439-019-02022-8
ORIGINAL INVESTIGATION
A commonly occurring genetic variant 
within the NPLOC4–TSPAN10–PDE6G gene cluster is associated 
with the risk of strabismus
Denis Plotnikov1 · Rupal L. Shah1 · Jamille N. Rodrigues2 · Phillippa M. Cumberland3,4 · Jugnoo S. Rahi3,4,5,6 · 
Pirro G. Hysi7 · Denize Atan2 · Cathy Williams2 · Jeremy A. Guggenheim1  · UK Biobank Eye and Vision Consortium
Received: 20 December 2018 / Accepted: 20 April 2019 
© The Author(s) 2019
Abstract
Strabismus refers to an abnormal alignment of the eyes leading to the loss of central binocular vision. Concomitant strabis-
mus occurs when the angle of deviation is constant in all positions of gaze and often manifests in early childhood when it 
is considered to be a neurodevelopmental disorder of the visual system. As such, it is inherited as a complex genetic trait, 
affecting 2–4% of the population. A genome-wide association study (GWAS) for self-reported strabismus (1345 cases and 
65,349 controls from UK Biobank) revealed a single genome-wide significant locus on chromosome 17q25. Approximately 
20 variants across the NPLOC4–TSPAN10–PDE6G gene cluster and in almost perfect linkage disequilibrium (LD) were most 
strongly associated (lead variant: rs75078292, OR = 1.26, p = 2.24E−08). A recessive model provided a better fit to the data 
than an additive model. Association with strabismus was independent of refractive error, and the degree of association with 
strabismus was minimally attenuated after adjustment for amblyopia. The association with strabismus was replicated in an 
independent cohort of clinician-diagnosed children aged 7 years old (116 cases and 5084 controls; OR = 1.85, p = 0.009). 
The associated variants included 2 strong candidate causal variants predicted to have functional effects: rs6420484, which 
substitutes tyrosine for a conserved cysteine (C177Y) in the TSPAN10 gene, and a 4-bp deletion variant, rs397693108, pre-
dicted to cause a frameshift in TSPAN10. The population-attributable risk for the locus was approximately 8.4%, indicating 
an important role in conferring susceptibility to strabismus.
Introduction
Strabismus refers to an abnormal alignment of the eyes lead-
ing to loss of binocular vision. Concomitant strabismus occurs 
when the angle of deviation is constant in all positions of gaze 
and often manifests in early childhood when it is considered 
to be a neurodevelopmental disorder of the visual system. 
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Concomitant strabismus is most often convergent (‘esotropia’) 
or divergent (‘exotropia’), although vertical misalignment may 
also occur as the primary deviation or in conjunction with eso- 
or exotropia. It is often associated with amblyopia (defined as 
poor visual acuity in one or both eyes not immediately correct-
able by glasses and without accompanying ocular pathology) 
in the deviated eye—either because the squint itself leads to 
secondary amblyopia in the deviated eye or because reduced 
vision in one eye compared with the other (e.g. anisometropia, 
unilateral cataract) secondarily leads to the squint. Therefore, 
concomitant strabismus is frequently associated with child-
hood-onset visual impairment, usually in one eye (Robaei et al. 
2006).
A variety of prenatal and early life environmental factors, 
such as prematurity, maternal smoking, and ill-health dur-
ing pregnancy, increase the risk of strabismus, as does a high 
hyperopic refractive error in early childhood (Cotter et al. 
2011; Pathai et al. 2010; Atkinson et al. 1996). Numerous stud-
ies have been conducted to understand the genetics of strabis-
mus (Graeber et al. 2013; Kruger et al. 2013; Maconachie et al. 
2013). Despite a complex inheritance pattern (Sanfilippo et al. 
2012; Ye et al. 2014; Georges et al. 2013), linkage analysis in 
pedigrees with multiple affected participants has implicated 
a locus at 7p22.1 (strabismus, susceptibility to, 1; STBMS1) 
consistent with the idea that rare, monogenic subtypes may 
exist (Parikh et al. 2003; Rice et al. 2009). Strabismus is also 
a feature of several rare syndromes—often in conjunction 
with intellectual disability—including examples such as Miet-
ens–Weber syndrome and Lamb–Shaffer syndrome.
Recently, Shaaban et al. (2018) tested the hypothesis that 
commonly occurring polymorphisms in the general popu-
lation increase the risk of non-syndromic strabismus, by 
carrying out a genome-wide association study (GWAS) for 
strabismus. They identified a locus within the first intron 
of WRB (tryptophan-rich basic protein) on chromosome 21 
(lead variant rs2244352; OR = 1.33, p = 9.58E−11). Here, 
we sought to test the same hypothesis in a larger sample, 
in order to increase statistical power. In view of the known 
association between strabismus and hyperopia, the refrac-
tive error of participants was included as a covariate in our 
GWAS analysis to avoid detecting genetic variants that 
increase the risk of strabismus secondary to hyperopia. The 
advent of the UK Biobank project facilitated this work, by 
providing a larger sample of cases with strabismus than has 
been studied before.
Materials and methods
Phenotypes in UK Biobank participants
Approximately 500,000 individuals aged 37–73  years 
were recruited into the UK Biobank cohort study between 
February 2006 and July 2010 (Sudlow et al. 2015). Ethi-
cal approval was obtained from the National Health Ser-
vice National Research Ethics Service (Ref 11/NW/0382) 
and all participants provided written informed consent. At a 
baseline visit to 1 of 22 assessment centres across the UK, 
participants completed a touch-screen questionnaire and 
underwent a series of physical assessments. From 2009, the 
physical assessments included an ophthalmic examination 
(Cumberland et al. 2016). Approximately 23% of partici-
pants underwent the ophthalmic assessment at the baseline 
visit, while an additional small proportion completed this 
assessment at the first of up to two follow-up visits. Based 
on their reason for wearing spectacles or contact lenses at 
the baseline or first follow-up visit [field #6147], participants 
were classified as having self-reported strabismus. Specifi-
cally, participants were asked ‘Why were you prescribed 
glasses/contact lenses? (You can select more than one 
answer)’. The response options were: (1) ‘For short-sighted-
ness, i.e. only or mainly for distance viewing such as driving, 
cinema, etc., (called “myopia”)’; (2) ‘For long-sightedness, 
i.e. for distance and near, but particularly for near tasks like 
reading (called “hypermetropia”)’; (3) ‘For just reading/near 
work as you are getting older (called “presbyopia”)’; (4) ‘For 
“astigmatism”; (5) ‘For a “squint” or “turn” in an eye since 
childhood (called “strabismus”)’; (6) ‘For a “lazy” eye or an 
eye with poor vision since childhood (called “amblyopia”)’; 
(8) ‘Other eye condition’, or (7) ‘Do not know’. Note that the 
age-of-onset, and the type of strabismus, for example esotro-
pia or exotropia, was not ascertained during the UK Biobank 
assessment, hence all subtypes would have been captured 
within the ‘self-reported strabismus’ phenotype. Similarly, 
information on strabismus surgery in childhood was not 
available (since data on hospital in-patient operations were 
collected only from April 1997 onwards). In addition, par-
ticipants who had strabismus, but who were not prescribed 
glasses/contact lenses because of the condition, would have 
been categorised as ‘controls’ rather than ‘cases’ for this 
self-reported strabismus phenotype.
Non-cycloplegic refractive error was measured after 
removal of habitual spectacles or contact lenses using a 
Tomey RC5000 autorefractor [fields #5084, #5085, #5086 
and #5087]. All repeat readings were averaged after removal 
of those flagged as unreliable [fields #5090 and #5091]. 
Spherical equivalent refractive error was calculated as 
sphere power plus half the cylinder power. The refractive 
error of an individual was taken as the average spherical 
equivalent of the two eyes (Tedja et al. 2018). Myopia was 
defined as a spherical equivalent refractive error ≤ − 0.50 
diopters (D). Refractive astigmatism was taken as the aver-
age cylinder power between the two eyes. A binary variable 
was used to classify individuals with astigmatism ≥ 1.00 D 
(Shah et al. 2018). Anisometropia was calculated as the 
difference in spherical equivalent between the two eyes. A 
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binary variable was used to classify individuals with aniso-
metropia ≥ 1.00 D (Qin et al. 2005).
Genetic data in UK Biobank participants
UK Biobank carried out DNA extraction from blood sam-
ples, and obtained high-density genotypes using either 
the UK BiLEVE array (n = 49,950) or the UK Biobank 
Axiom array (n = 438,427). Prior to release of the genetic 
data (“July 2017 release”), Bycroft et al. (2018) performed 
extensive quality control of the genotype data and imputed 
additional genotypes using the HRC reference panel (McCa-
rthy et al. 2016). Imputed genotype data were available for 
488,377 individuals. Participants who had withdrawn con-
sent were removed, as were those not in the White British 
European ancestry subset defined by Bycroft et al. (2018), 
those whose genetic sex did not match their self-reported 
gender, and those with heterozygosity more than 4 standard 
deviations from the mean. A set of well-imputed variants 
(with IMPUTE2 INFO metric > 0.9, MAF > 0.005, missing 
rate ≤ 0.01, and an ‘rs’ variant ID prefix) were selected and 
LD-pruned using the --indep-pairwise 50 5 0.1 command in 
PLINK 2.0 (Chang et al. 2015). These were used to create a 
genetic relationship matrix (GRM) with PLINK 2.0 in order 
to identify a set of unrelated individuals (command --rel-
cutoff 0.025). Note that phenotype information was not taken 
into account when selecting a set of unrelated participants. 
This left 338,253 unrelated participants of White British 
ancestry.
As shown in Fig. 1, further exclusions were made for par-
ticipants who: did not have a response for the questionnaire 
item [field #6147] ‘Why were you prescribed glasses/contact 
lenses?’; did not have valid autorefraction information; self-
reported a history of laser refractive surgery [field #5325], 
cataract surgery [field #5324; #20004; ICD 1435], corneal 
graft surgery [field #5328], any other eye surgery in the last 
4 weeks [field #5181], any eye trauma resulting in sight loss 
[#5419, #6148], serious eye problems [field #6148], or self-
report of having cataracts [fields #5441, #6148; #20004; 
ICD 1278] or retinal detachment [field #20004; ICD 1281]. 
Participants were also excluded if their hospital records 
[field #41200] indicated they had undergone cataract surgery 
[OPCS-4: C711, C712, C718, C719, C723, C751], retinal 
detachment surgery [OPCS-4: C548, C549, C543, C545], or 
corneal surgery [OPCS-4: C442, C444, C445, C448, C461, 
C462, C463, C465, C493]. The final UK Biobank ‘discovery 
sample’ comprised 66,694 participants.
Genome‑wide association study for strabismus 
in UK Biobank participants
A GWAS for self-reported strabismus was carried out for 
the 1345 cases and 65,349 controls in the discovery sample. 
Firth logistic regression was performed (--glm-firth com-
mand in PLINK 2.0) for 7,469,170 imputed variants in the 
HRC reference panel with MAF ≥ 1%, INFO > 0.8, missing 
genotype rate < 1.5%, and HWE p value > 1.0e−06. Only 
individuals with a missing genotyping rate < 2.5% were 
included. Age, gender, refractive error averaged between the 
two eyes, genotyping array (UK BiLEVE or UK Biobank 
Axiom, coded as a binary variable), and the first 10 ancestry 
PCs were included as covariates.
Post‑GWAS analyses
Fine-mapping of the NPLOC4–TSPAN10–PDE6G region 
was carried out using FINEMAP v1.3 (Benner et al. 2016). 
Parcipants aer removal of 
those withdrawing consent
(n=488,366)
White Brish ancestry
Unrelated
(n=338,253)
Answered ‘Reason for 
glasses/contact lenses’
(n=79,727)
Parcipants with valid 
autorefracon data
(n=75,911)
No self-reported or hospital 
recorded ocular pathology
(n=66,694)
UKB parcipants with genotype 
data available
(n=488,377)
Associaon study for strabismus 
(cases=1,345; controls=65,349)
Fig. 1  Flow diagram illustrating the selection of UK Biobank partici-
pants for the GWAS sample
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All SNPs on the HRC reference panel within ± 250 kb of the 
lead variant rs75078292 or that were in LD (r2 > 0.1) with 
the lead variant were included in the analysis. Up to 5 causal 
variants in the region were considered, with a prior prob-
ability within the range 0.583–0.005 of having 1–5 causal 
variants. The Genotype-Tissue Expression consortium 
(GTEx) Portal (The GTEx Consortium 2015) was accessed 
on 09/18/2018 to identify expression quantitative trait loci 
(eQTL) for genes situated at the locus regulated by the lead 
SNP identified in the GWAS (so-called ‘eGenes’).
Statistical analyses and population‑attributable risk
Statistical tests were performed using R (R Development 
Core Team 2008). Standard logistic regression models were 
fitted using the glm function, while Firth regression mod-
els were fitted using the brglm function from the brlrmr 
package. A likelihood ratio test was used to compare the 
fit of additive vs. dominant or additive vs. recessive models 
(Bagos 2013). This was accomplished by deriving dummy 
variables and fitting nested models, as described in Online 
Resource 1. In view of the low prevalence (2–4%) of stra-
bismus, we made the assumption that the relative risk was 
approximately equal to the odds ratio (OR), and therefore the 
population-attributable risk (PAR) due to the lead GWAS 
variant was estimated with the formula (Qi et al. 2011): 
PAR = p (OR−1)/[p (OR−1)] + 1, where p is the proportion 
of controls with the risk genotype. The IMPUTE2 INFO 
score for the lead GWAS variants rs75078292 was 0.999, 
suggesting that there was no loss in accuracy by using 
‘hard’ genotype calls in the above models rather than dos-
age accounting for genotype uncertainty.
ALSPAC replication sample
The Avon Longitudinal Study of Parents and Children 
(ALSPAC) (Boyd et  al. 2013; Fraser et  al. 2012) is a 
birth cohort study that recruited 14,541 pregnant women 
resident in Avon, UK, with expected dates of delivery 
01/04/1991–31/12/1992. Of these initial pregnancies, 13,988 
children were alive at 1 year of age. When the oldest children 
were approximately 7 years of age, an attempt was made to 
bolster the initial sample with eligible cases who had failed 
to join the study originally. This resulted in an additional 811 
children joining the study. Ethical approval for the study was 
obtained from the ALSPAC Ethics and Law Committee and 
the Local Research Ethics Committees. Please note that the 
study website (http://www.brist ol.ac.uk/alspa c/resea rcher 
s/our-data/) contains details of all the data that are avail-
able through a fully searchable data dictionary and variable 
search tool.
DNA extraction, genotyping and imputation of ALSPAC 
participants has been described previously (Taylor et al. 
2016). Imputed genotype data were available for a total of 
8237 children. Eye movements were assessed by an orthop-
tist when ALSPAC participants were aged 7 years old (Wil-
liams et al. 2008). Ocular misalignment was quantified by 
simultaneous prism cover test and alternate prism cover test, 
at near (33 cm) and distance (6 m) with and without glasses, 
if worn. Strabismus was classified as ‘manifest’ if present 
in normal viewing with both eyes open. Horizontal strabis-
mus was categorised as esotropia (convergent) or exotropia 
(divergent) and included manifest and large latent deviations 
(> 10 pd for convergent and > 15 pd for divergent) so as to 
be more likely to capture intermittent or decompensating 
cases. Logistic regression was used to examine the associa-
tion between each ocular phenotype and rs6420484 genotype 
(coded either as additive or recessive) in the 5200 children 
with genotype and ocular phenotype data available. The phe-
notypes examined were: parentally reported history of stra-
bismus (n = 145 cases), manifest strabismus (n = 116 cases), 
esotropia (n = 143 cases) and exotropia (n = 28 cases).
Retinal immunohistochemistry
Immunostaining of adult mouse retinal sections (> 8 weeks 
old) was performed as previously described (Jung et al. 
2015). Antibodies were used at the following dilutions: pea-
nut agglutinin conjugated to Alexa 488 (1:500), mouse anti-
rhodopsin (1:5000), rabbit anti-TSPAN10 (1:1000), mouse 
anti-GOalpha (1:500), rabbit NPLOC4 (1:10), and mouse 
anti-PKC (1:1000). Images were acquired using a Leica laser 
scanning confocal microscope.
Results
Validation of self‑reported strabismus
There were 72,911 unrelated UK Biobank participants who 
reported their country of birth as England, Wales or Scot-
land, whose genetic ancestry principal components clustered 
with other White British Europeans, and who had responded 
to the questionnaire item ‘Why were you prescribed glasses/
contact lenses? (You can select more than one answer)’ as 
well as undergoing an autorefraction assessment. After fur-
ther removal of participants with a history of ocular pathol-
ogy, this left 66,694 individuals (Fig. 1). A total of 1345 
(2.0%) of participants reported ‘squint or a turn in an eye 
since childhood’ as a reason for wearing glasses or con-
tact lenses. Participants with self-reported strabismus had 
a 11.3-fold greater prevalence of self-reported amblyopia, a 
2.5-fold greater prevalence of 1.00 D or more anisometro-
pia, a much more hypermetropic refractive error (median 
+ 2.46 vs. + 0.21 D), and a much earlier age of starting to 
wear glasses or contact lenses (median 5 vs. 40 years old) 
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(Table 1; Fig. 2). For age and gender, the cases and con-
trols were well-matched (Table 1), and the difference in 
Townsend Deprivation Index, a measure of socioeconomic 
position, in those who did vs. did not report having stra-
bismus was modest (− 1.84 vs − 2.12; p = 4.40E−03). All 
of these comparisons between cases and controls supported 
the validity of the self-reported strabismus phenotype in the 
majority of participants.
Genome‑wide association study for self‑reported 
strabismus identifies a locus on 17q25.3
Standard logistic regression is susceptible to bias in highly 
unbalanced case–control studies, which can result in either 
conservative or anti-conservative test behaviour (Ma et al. 
2013). We therefore carried out our GWAS analysis using 
Firth bias-corrected logistic regression. A total of 7,469,170 
genetic variants were tested for association with self-
reported strabismus in the sample of 1345 cases and 65,349 
controls (Fig. 1). As well as standard GWAS covariates such 
as age, sex and PCs, we included refractive error averaged 
between the two eyes as an additional covariate in order to 
mitigate against identifying genetic variants primarily asso-
ciated with this comorbid trait.
Variants located on chromosome 17q25.3 were found 
to be significantly associated with strabismus (Fig. 3). The 
most strongly associated variant was rs75078292, OR = 1.26, 
95% CI 1.16–1.36, p = 2.24E−08. Markers in other regions 
did not attain genome-wide significance; the lead variant 
in all regions that include a marker with p < 1.0E−05 are 
listed in Online Resource 2. The strabismus GWAS analysis 
showed no evidence of population stratification (λGC = 1.004; 
Online Resource 3).
The lead variant, rs2244352, identified in the non-accom-
modative esotropia case–control GWAS reported by Shaaban 
et al. (2018) was not associated with self-reported strabis-
mus in the current GWAS (OR = 1.01, 95% CI 0.93–1.10, 
p = 0.83).
Fine‑mapping of the 17q25.3 locus
Conditional analysis suggested that a single vari-
ant in the region was driving the association at the 
NPLOC4–TSPAN10–PDE6G locus (Fig. 4). To investigate 
this further, we used the FINEMAP Bayesian fine-mapping 
approach developed by Benner et al. (2016), which exploits a 
shotgun stochastic search algorithm to greatly increase com-
putational performance when evaluating the evidence for 
multiple causal variants in a genomic region. However, this 
analysis was not able to infer the precise causal variant(s) 
from amongst the approximately 20 variants in almost per-
fect LD. Since the associated variants at the locus have 
widely varying MAF across ancestry groups (Fig. 5), future 
fine-mapping efforts may be more successful in populations 
of non-European ancestry.
Mode of inheritance attributable to the NPLOC4–
TSPAN10–PDE6G locus
We explored if an additive, dominant or recessive model best 
described the relationship between rs75078292 genotype 
and strabismus. An additive model provided a better fit than 
a dominant model (p = 4.76E−06) while a recessive model 
provided a better fit than the additive model (p = 8.10E−05). 
The same pattern of results was evident after including the 
presence/absence of amblyopia, refractive error, astigma-
tism, and/or anisometropia as covariates in the analysis 
(Table 2).
Under the recessive model, the risk of strabismus 
in the 14.8% of the sample homozygous for the minor 
Table 1  Demographic and ocular characteristics of the UK Biobank strabismus GWAS sample
Variable All (n = 66,694) Cases (self-reported 
strabismus; n = 1345)
Controls (n = 65,349) p value
Female N (%) 35,758 (53.6%) 803 (59.7%) 34,955 (53.5%) 2.20E−01
Self-reported unilateral amblyopia N (%) 2465 (3.7%) 471 (35.0%) 1994 (3.1%) < 1.0E−99
Both eyes VA ≤ 0.0 logMAR N (%) 30,098 (45.1%) 266 (19.8%) 29,832 (45.6%) < 1.0E−99
VA difference ≥ 0.2 logMAR N (%) 13,135 (19.7%) 624 (46.4%) 12,511 (19.1%) < 1.0E−99
Better VA ≤ 0.0; VA difference ≥ 0.2 N (%) 9123 (13.7%) 454 (33.8%) 8669 (13.3%) < 1.0E−99
Anisometropia ≥ 1.0 D N (%) 11,156 (16.7%) 553 (41.1%) 10,603 (16.2%) < 1.0E−99
Anisometropia ≥ 2.0 D N (%) 3948 (5.9%) 261 (19.4%) 3687 (5.6%) < 1.0E−99
Age Median (IQR) 60.17 (53.33 to 64.42) 60.17 (53.67 to 64.83) 60.17 (53.33 to 64.42) 2.30E−01
Refractive error (D) average of 2 eyes Median (IQR) 0.23 (− 1.41 to 1.26) 2.46 (0.52 to 4.65) 0.21 (− 1.44 to 1.22) < 1.0E−99
Anisometropia (D) Median (IQR) 0.36 (0.16 to 0.73) 0.75 (0.30 to 1.67) 0.35 (0.15 to 0.72) 8.00E−94
Age started wearing glasses (years) Median (IQR) 39.00 (15.00 to 47.00) 5.00 (3.00 to 8.00) 40.00 (16.00 to 47.50) < 1.0E−99
Townsend Deprivation Index Median (IQR) − 2.12 (− 3.59 to 0.25) − 1.84 (− 3.46 to 0.63) − 2.12 (− 3.59 to 0.25) 4.40E−03
 Human Genetics
1 3
allele of rs75078292 was OR = 1.62 (95% CI 1.41–1.86, 
p = 1.01E−11). This suggested that the population-attribut-
able risk due to the locus was approximately 8.4%.
Co‑localisation of association signals for strabismus 
and refractive error
The NPLOC4–TSPAN10–PDE6G locus was identified in a 
previous GWAS for self-reported myopia by Pickrell et al. 
(2016) carried out using data for individuals of European 
ancestry from the personal genomics company 23andMe. 
The variant most strongly associated with refractive error 
in the Pickrell et al. study was rs9747347, which is in 
perfect LD with the lead strabismus variant (r2 = 1.00). In 
analyses adjusted for age, sex, genotyping array and the 
first 10 PCs, we found that the strabismus risk allele of 
rs75078292 was also associated with myopia (OR = 1.06, 
p = 5.78E−07) and refractive error (regression coeffi-
cient = − 0.09 D, 95% CI − 0.12 to − 0.06, per copy of 
the risk allele, p = 2.77E−08) in UK Biobank participants 
consistent with the perfect LD between rs9747347 and the 
similar frequencies of their respective risk alleles. Adjust-
ing for amblyopia or strabismus had minimal impact on 
the magnitude of the association between rs75078292 and 
either myopia or refractive error.
After stratifying the sample into myopic, emmetropic and 
hyperopic subsamples (Table 3), there was no longer evi-
dence of an association between rs75078292 genotype and 
strabismus in the myopic stratum (OR = 1.11, p = 6.19E−01), 
whereas the association in the hyperopic stratum remained 
strong (OR = 1.64, p = 8.30E−07). Association was evident 
in emmetropes (OR = 1.88, p = 7.24E−03) but the statisti-
cal support was weaker than in hyperopes, likely due to the 
difference in the prevalence of strabismus between these 
subsamples (0.8% in emmetropes vs. 5.0% in hyperopes). 
The stratified analysis therefore provided further evidence 
that the association between rs75078292 and strabismus was 
not driven by refractive error.
Fig. 2  Clinical and demo-
graphic characteristics of 
participants self-reporting 
strabismus compared to controls 
(n = 1345 cases and n = 65,349 
controls). Early age-of-onset of 
glasses was defined as ≤ 7 years. 
Bar chart error bars denote 95% 
CI. For violin plots, the white 
rectangle corresponds to the 
interquartile range and the solid 
black circle to the median
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Functional evaluation of the 17q25.3 locus
Notably, the lead variant at the strabismus locus, 
rs75078292, is in very tight LD (r2 = 0.98) with non-syn-
onymous variant rs6420484, which introduces a tyrosine 
residue in place of an evolutionarily conserved cysteine 
at position 177 of TSPAN10, the gene encoding tetras-
panin-10 (Online Resource 4). The C177Y substitution 
would be expected to have adverse functional conse-
quences, given its scaled CADD score of 16.3 (Table 4). 
Fig. 3  Manhattan plot for self-
reported strabismus GWAS. 
The y axis indicates minus 
 log10 p values and the x axis 
genomic position. The red and 
blue horizontal lines correspond 
to p values of 5.0E−08 and 
1.0E−05, respectively
Fig. 4  Regional association plot 
for self-reported strabismus in 
the region of strongest asso-
ciation, before (a) and after (b) 
conditioning on the lead variant
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The strabismus lead variant rs75078292 and the C177Y-
associated variant rs6420484 are also in extremely 
high LD with an indel, rs397693108, also predicted to 
have functional consequences (CADD score 16.1). The 
rs397693108 indel introduces a 4-bp deletion in the mRNA 
for 2 isoforms of tetraspanin-10, which would result in a 
frameshift in the coding region. For a third isoform, the 
indel is predicted to result in nonsense-mediated decay 
(NMD) of the mRNA. The risk alleles of the C177Y-asso-
ciated variant rs6420484 and indel rs397693108 have the 
same MAF, which given their high LD (r2 = 0.98) implies 
they occur on the same haplotype. CADD scores for other 
variants in LD with the lead GWAS variant were lower 
(Table 4).
Fig. 5  Allele frequency spectrum and of lead GWAS variant across 
ancestry groups. Allele frequencies for rs75078292. Abbreviations: 
AFR, Africans; AMR, Native Americans; EAS, East Asians; EUR, 
Europeans; SAS, South Asians). The results were obtained from 
Ensembl (Yates et al. 2016) for participants of the 1000-genomes pro-
ject (The 1000 Genomes Project Consortium 2012)
Table 2  Comparison of modes of inheritance of lead variant at the NPLOC4–TSPAN10–PDE6G locus for association with self-reported strabis-
mus in UK Biobank participants (n = 66,694)
Baseline model included covariates: age, sex, first 10 PC, genotyping array; covariate definitions. Refractive error = mean spherical equivalent 
refractive error in diopters averaged between the two eyes; anisometropia = anisometropia in diopters coded as a continuous variable; astigma-
tism = refractive astigmatism in diopters averaged between the two eyes; myopia status = binary variable coded as zero unless refractive error 
averaged between the two eyes ≤ −0.5 D; anisometropia status = binary variable coded as zero unless anisometropia ≥ 1.00 D; astigmatism sta-
tus = binary variable coded as zero unless refractive astigmatism averaged between the two eyes ≥ 1.00 D
Covariates included in model Additive model Dominant model Recessive model
OR 95% CI p value OR 95% CI p value OR 95% CI p value
Baseline 1.24 1.14–1.34 8.92E−08 1.16 1.04–1.29 1.03E−02 1.62 1.41–1.86 1.01E−11
Baseline + amblyopia status 1.16 1.08–1.26 1.70E−04 1.11 0.99–1.24 7.66E−02 1.42 1.23–1.64 2.16E−06
Baseline + refractive error 1.26 1.16–1.36 2.24E−08 1.19 1.06–1.33 3.04E−03 1.64 1.42–1.89 1.61E−11
Baseline + anisometropia 1.23 1.13–1.33 2.97E−07 1.16 1.03–1.29 1.13E−02 1.58 1.37–1.82 1.65E−10
Baseline + astigmatism 1.21 1.12–1.31 2.01E−06 1.13 1.01–1.26 3.45E−02 1.57 1.36–1.81 4.47E−10
Baseline + myopia status 1.25 1.16–1.35 1.71E−08 1.17 1.05–1.31 5.39E−03 1.66 1.44–1.90 1.25E−12
Baseline + anisometropia status 1.22 1.13–1.32 7.28E−07 1.15 1.03–1.29 1.38E−02 1.55 1.35–1.78 8.50E−10
Baseline + astigmatism status 1.22 1.12–1.32 1.07E−06 1.14 1.02–1.28 2.23E−02 1.57 1.36–1.81 3.77E−10
Table 3  Association of lead 
variant for strabismus at the 
NPLOC4–TSPAN10–PDE6G 
locus with self-reported 
strabismus after stratifying by 
refractive status
Participants were classified into refractive error categories based on their spherical equivalent refractive 
error in each eye meeting the following criteria: myopes: ≤ − 0.5 D; emmetropes: > − 0.5 D and ≤ + 1.0 D; 
hyperopes: > + 1.0 D. Note that participants whose two eyes were not classified into the same group (e.g. 
one eye myopic and one eye emmetropic) were excluded. The baseline covariates age, sex, genotyping 
array, and the first 10 PCs were included in all models
a Adjusted for baseline covariates plus presence/absence of amblyopia, presence/absence of strabismus, and 
anisometropia (D)
Stratum Covariates Cases/controls Additive model Recessive model
OR 95% CI p value OR 95% CI p value
Myopes Baseline 162/20,473 1.15 0.93–1.44 1.99E−01 1.11 0.73–1.70 6.19E−01
Emmetropes Baseline 104/17,705 1.22 0.93–1.60 1.51E−01 1.88 1.19–2.99 7.24E−03
Hyperopes Baseline 807/16,217 1.28 1.15–1.42 3.19E−06 1.64 1.35–1.99 8.30E−07
Myopes Adjusteda 162/20,473 1.15 0.92–1.44 2.09E−01 1.11 0.72–1.70 6.44E−01
Emmetropes Adjusteda 104/17,705 1.18 0.89–1.55 2.51E−01 1.77 1.10–2.84 1.96E−02
Hyperopes Adjusteda 807/16,217 1.18 1.06–1.31 2.26E−03 1.47 1.20–1.80 1.86E−04
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To search for further evidence of a functional effect of 
the frameshift/NMD-causing indel rs397693108, we exam-
ined TSPAN10 gene expression in tissue samples analysed 
by the GTEx consortium (The GTEx Consortium 2015). 
Although the tissues potentially most relevant to strabis-
mus development, such as extraocular muscle, retina and 
visual cortex, were not amongst the 53 tissues assessed by 
the GTEx Consortium, the regulation of gene expression is 
often conserved across tissue types and therefore can still 
be highly informative (Pierson et al. 2015). In cerebellum 
and human cerebellar hemisphere the strabismus-associated 
risk allele was strongly associated with reduced expression 
of TSPAN10 (p = 1.30E−10 and p = 8.10E−12, respectively; 
Fig. 6a, b) consistent with degradation of an mRNA isoform 
via NMD. Furthermore, there was evidence for cis-eQTL 
effects at two other genes. In testis, the risk allele was asso-
ciated with reduced phosphodiesterase 6G gene (PDE6G) 
expression (p = 5.82E−06; Fig. 6c), while in thyroid, it was 
associated with expression of ADP ribosylation factor like 
GTPase 16 (ARL16) mRNA levels (p = 2.10E−06; Fig. 6d). 
In testis, rs397693108 was the 47th-ranked eSNP associated 
with PDE6G expression; however, it had an almost 1.6-fold 
lower effect than the top-ranked variant located 15 kb dis-
tant (rs11150804, p = 1.80–41). Like PDE6G, the ARL16 
gene encoding ADP ribosylation factor like GTPase 16 is 
located nearby to NPLOC4 and TSPAN10 (Fig. 4). In thy-
roid, rs397693108 was the 232nd ranked eSNP associated 
with ARL16 expression, and had a more than fourfold lower 
effect than the top-ranked variant situated 34.5 kb away 
(rs7503637, p = 5.50E−96). By contrast, rs397693108 
was the 15th highest-ranked TSPAN10 eQTL in cerebel-
lum and had an effect size equal to the top-ranked variant 
(rs9905786, p = 7.20E−122). In cerebellar hemisphere tissue 
rs397693108 was the 63rd-ranked TSPAN10 eQTL.
Structural variants (SVs) are also known to regulate gene 
expression, including at the 17q25.3 locus where Chiang 
et al. (2017) found evidence for co-regulation of TSPAN10 
gene expression by SVs and SNPs. Thus, in summary, there 
was strong evidence that the causal variant underlying the 
association with strabismus acts as a cis-eQTL for TSPAN10 
in neural tissue, and for PDE6G and ARL16 in certain other 
tissues. Of these three eGenes, the evidence suggested 
TSPAN10 as the most likely causal eGene. However, since 
gene expression can be highly tissue-specific, further func-
tional studies will be required to examine if eQTL effects are 
important in the mechanism by which this locus influences 
strabismus development.
Independent replication in a clinician‑diagnosed 
sample of children
We sought independent replication of the findings from 
UK Biobank in a sample of 7-year-old children (n = 5200) 
from the ALSPAC cohort who were clinically assessed for 
Table 4  CADD scores and eQTL effects for TSPAN10 gene expression in cerebellum for variants surpassing the genome-wide significance 
threshold and in very high LD (r2 > 0.95) with the lead variant at the locus
SNP CHR BP REF ALT GWAS OR GWAS p value MAF Scaled 
CADD 
score
eQTL p value eQTL effect size
rs6420484 17 79612397 A G 1.21 8.24E−10 0.35 16.29 3.30E−21 0.84
rs397693108 17 79614932 TTAAC T 1.21 6.90E−10 0.35 16.08 3.30E−21 0.84
rs9895741 17 79603831 A G 1.21 1.43E−09 0.35 10.84 3.30E−21 0.84
rs9747347 17 79606820 T C 1.21 1.27E−09 0.35 7.09 1.80E−21 0.84
rs7405453 17 79615572 A G 1.21 5.02E−10 0.35 6.92 3.30E−21 0.84
rs62075722 17 79611271 A G 1.21 8.48E−10 0.35 6.29 3.30E−21 0.84
rs67050149 17 79557043 C A 0.83 1.25E−09 0.35 5.98 3.30E−21 − 0.84
rs11656126 17 79564542 G A 0.83 7.96E−10 0.35 5.98 3.00E−21 − 0.84
rs8081701 17 79599441 T C 1.21 1.47E−09 0.35 2.41 5.40E−21 0.86
rs11650127 17 79572253 G A 0.83 6.00E−10 0.35 1.85 1.70E−20 − 0.84
rs71373084 17 79564930 C G 0.83 8.03E−10 0.35 1.65 3.40E−21 − 0.84
rs9905786 17 79602063 G T 1.21 1.44E−09 0.35 1.08 7.20E−22 0.86
rs112364254 17 79578287 G A 0.82 4.93E−10 0.35 1.04 2.70E−20 − 0.82
rs7503894 17 79583473 T C 1.21 5.94E−10 0.35 0.64 3.30E−21 0.84
rs12953229 17 79554271 G A 0.83 9.50E−10 0.35 0.48 3.30E−21 − 0.84
rs75078292 17 79585492 A G 1.21 7.95E−10 0.35 0.38 3.20E−21 0.84
rs62075723 17 79611326 G A 1.21 5.91E−10 0.35 0.15 3.30E−21 0.84
rs34635363 17 79549250 G A 0.83 9.34E−10 0.35 0.13 3.30E−21 − 0.84
rs12948708 17 79558741 G A 0.83 9.34E−10 0.35 0.02 3.30E−21 − 0.84
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strabismus by an experienced orthoptist. The results are 
presented in Table 5. The association with strabismus was 
replicated in the clinician-diagnosed sample of children 
(Table 5). For any manifest strabismus, the OR = 1.44 (95% 
CI 1.11–1.88, p = 0.007) and OR = 1.85 (95% CI 1.16–2.95, 
p = 0.009) for additive and recessive models, respectively, 
were consistent with UK Biobank in terms of risk allele, 
effect size and likely mode of inheritance. Adjusting for 
amblyopia in these analyses had negligible impact (Table 5). 
It was notable that the association with strabismus appeared 
to be restricted to exotropia (divergent strabismus). However, 
some of the children may have had exotropia resulting from 
surgery to correct esotropia, hence this latter result should 
be interpreted with caution (especially in view of the small 
number of only 28 children with exotropia in the ALSPAC 
sample).
Tissue distribution of TSPAN‑10 in mouse retina
In the mouse retina, tetraspanin-10 co-localised with Pea-
nut Agglutinin Lectin (PNA), which is a marker of cone 
photoreceptor inner and outer segments. There was no co-
localisation with rhodopsin, a rod photoreceptor marker 
(Fig.  7). NPL4 homolog, ubiquitin recognition factor 
(NPLOC4) co-localised with G Protein subunit alpha O1 
(G0alpha), which is a marker of ON bipolar cells, but not 
Fig. 6  Strabismus-associated indel rs397693108 is an eQTL. Gene 
expression levels of tetraspanin-10 mRNA in cerebellum (a) and 
human cerebellar hemisphere (b), and of phosphodiesterase 6G in 
testis (c), and of ADP ribosylation factor like GTPase 16 in thyroid 
(d) for individuals with the indicated rs397693108 genotype (Ref 
allele = TTAAC, Del allele = T). Numbers indicate the number of 
donors for each genotype category. Boxes depict the first and third 
quartile; whiskers extend to the furthest data point up to a maximum 
of 1.5 times the height of the box
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with Protein kinase-C alpha (PKC), a marker of rod bipo-
lar cells (Fig. 8). This suggested TSPAN10 is expressed 
in cone photoreceptors and NPLOC4 in ON-cone bipolar 
cells in the mouse retina. Previous studies have shown 
that phosphodiesterase 6G (PDE6G) is expressed in both 
rod and cone photoreceptors (Dvir et al. 2010).
Discussion
These results provide strong evidence that a commonly 
occurring polymorphism situated within a high-LD cluster 
of approximately 20 variants on chromosome 17q25.3 con-
tributes to susceptibility to strabismus. This association with 
strabismus was independent of the previously documented 
association with myopia at this locus, since the degree of 
association with strabismus was minimally attenuated by 
Table 5  Association of 
amblyopia and strabismus with 
lead GWAS variant in ALSPAC 
replication sample
Baseline model adjusted for sex. Adjusted amblyopia analysis: adjusted for sex and strabismus. Adjusted 
strabismus analyses: adjusted for sex and amblyopia
Note ‘Esotropia’ includes large (> 10 pd) esophoria as well as manifest esotropia and ‘Exotropia’ similarly 
includes large (> 15 pd) exophoria as well as manifest exotropia, hence N of esotropia + exotropia is greater 
than for manifest strabismus, which includes only cases manifest on the day of examination
Phenotypes were ascertained in children at age of 7 years
Phenotype Sample size 
cases/con-
trols
Inheritance Baseline model Adjusted model
OR (95% CI) p value OR (95% CI) p value
History of strabismus 145/5055 Additive 1.36 (1.07–1.73) 0.011 1.34 (1.04–1.73) 0.026
Recessive 1.72 (1.12–2.63) 0.013 1.58 (0.98–2.55) 0.061
Manifest strabismus 116/5084 Additive 1.44 (1.11–1.88) 0.007 1.43 (1.07–1.92) 0.016
Recessive 1.85 (1.16–2.95) 0.009 1.72 (1.00–2.95) 0.050
‘Esotropia’ 143/5057 Additive 1.08 (0.85–1.38) 0.542 1.02 (0.78–1.32) 0.910
Recessive 1.20 (0.74–1.95) 0.450 1.00 (0.59–1.72) 0.989
‘Exotropia’ 28/5172 Additive 1.76 (1.04–2.99) 0.035 1.73 (1.02–2.93) 0.040
Recessive 2.47 (1.05–5.83) 0.039 2.37 (1.00–5.63) 0.051
Amblyopia 189/5011 Additive 1.19 (0.97–1.48) 0.100 0.97 (0.77–1.23) 0.789
Recessive 1.36 (0.91–2.02) 0.135 1.10 (0.69–1.74) 0.690
Fig. 7  Immuno-localisation of tetraspanin-10 in the mouse retina. a Tetraspanin-10 co-localised with Peanut Agglutinin Lectin (PNA), a cone 
photoreceptor inner and outer segment marker. b Tetraspanin-10 did not co-localise with rhodopsin, a rod photoreceptor marker
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statistical adjustment for refractive error, myopia status, or 
anisometropia. These findings suggest a new avenue for stra-
bismus research; namely, to discover how and why gene(s) at 
the NPLOC4–TSPAN10–PDE6G locus influence the visual 
system’s response to visual experience in childhood. Our 
results add to the evidence from the GWAS carried out by 
Shaaban et al. (2018), that commonly occurring variants 
contribute to susceptibility for strabismus. Notably, the lead 
variant (rs2244352) associated with non-accommodative 
esotropia in the Shaaban et al. GWAS was not associated 
with self-reported strabismus in the current study, suggest-
ing the possibility that the association with rs2244352 is 
specific to non-accommodative esotropia rather than stra-
bismus more generally.
We reasoned that three criteria should be met in order for 
a case–control GWAS to detect genetic variants associated 
with a trait-of-interest. First, the trait must have a genetic 
component. Second, the sample of ‘controls’ should contain 
relatively few individuals truly affected by the disorder, i.e. 
a low proportion of misclassified cases. Third, the sample 
of ‘cases’ must be enriched for individuals truly affected by 
the disorder. Regarding our first criterion, recent progress 
in identifying mutations causing strabismus (Maconachie 
et al. 2013; Ye et al. 2014; Kruger et al. 2013; Shaaban et al. 
2018) provided support for the hypothesis that susceptibil-
ity to strabismus has a genetic component. In their pioneer-
ing study employing a set of shared controls, the Wellcome 
Trust Case Control Consortium (2007) carried out simu-
lations demonstrating that statistical power was minimally 
reduced if fewer than 5% of ‘controls’ were actually misclas-
sified/undiagnosed cases. Given the known prevalence of 
strabismus in the population (2–4%), selecting controls as 
participants who did not self-report strabismus was there-
fore considered an effective approach for meeting our second 
criterion. To meet our third criterion we sought to confirm 
that the group of UK Biobank participants who self-reported 
strabismus was enriched for people with ‘true’ strabismus. 
To do this, we analysed the level of comorbid traits such as 
self-reported amblyopia, anisometropia and asymmetric VA 
in self-reported strabismus cases and controls, which dem-
onstrated convincingly that the comorbidities were indeed 
over-represented amongst cases (Table 1; Fig. 2). Most 
importantly, we verified that the association with strabis-
mus was replicated in an independent cohort of 7-year-old 
children with clinician-diagnosed strabismus (OR = 1.85, 
95% CI 1.16–2.95).
Fig. 8  Immuno-localisation of NPL4 homolog, ubiquitin recogni-
tion factor (NPLOC4) in the mouse retina. a–c NPLOC4 co-localised 
with G0alpha, which a marker for the dendritic tips of ON bipolar 
interneurons. d–f NPLOC4 did not co-localise with protein kinase-C 
(PKC), a marker for rod bipolar interneurons including their dendrites
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There was suggestive evidence that the association with 
strabismus was restricted to non-myopic individuals, and—
counter-intuitively—to individuals with exotropia rather 
than esotropia. To further dissect these inter-relationships 
will require the collection and genotyping of large case–con-
trol samples, or Biobank-scale cohorts, of individuals with 
clinician-diagnosed strabismus. In view of the worldwide 
differences in allele frequency of the lead variant at the 
NPLOC4–TSPAN10–PDE6G locus (Fig. 5), GWAS analyses 
in other ancestry groups should prove fruitful.
Genetic variants at the NPLOC4–TSPAN10–PDE6G 
locus have been associated with a diverse range of ocular 
phenotypes. As well as the previously mentioned associa-
tion of variants at the novel strabismus locus being asso-
ciated with spherical refractive error, Shah et al. (2018) 
recently reported that these variants were also associated 
with corneal and refractive astigmatism (independently of 
spherical refractive error), while Gao et al. (2019) reported 
that rs7405453, which is in perfect LD with the lead stra-
bismus variant rs75078292 (r2 = 1.0) was associated with 
macular thickness. Two SNPs within NPLOC4 (rs6565597 
and rs9894429) are associated with age-related macular 
degeneration (AMD) and eye colour, respectively (Fritsche 
et al. 2015; Liu et al. 2010). Missense variant rs201259422, 
which is located only 2.5 kb from the TSPAN10 C177Y-
associated variant and introduces a D266N amino acid 
substitution in TSPAN10, is associated with microvas-
cular (central retinal venule) diameter in human retina 
(Jensen et al. 2016). Given the association of variants at the 
NPLOC4–TSPAN10–PDE6G locus and AMD, we carried 
out a sensitivity analysis examining the association between 
strabismus and rs75078292 after excluding UK Biobank par-
ticipants with self-reported AMD. The results were mini-
mally affected (Online Resource 5).
Under the most parsimonious inheritance model—reces-
sive inheritance—the magnitude of the association with stra-
bismus (OR ≈ 1.4–1.8) is much larger than those typically 
reported in GWAS studies of complex traits (MacArthur 
et al. 2017). In view of the wide range of adverse effects 
associated with the NPLOC4–TSPAN10–PDE6G locus, it 
is conceivable that the locus has compensatory beneficial 
effects on other traits.
In silico functional prediction suggested TSPAN10 as 
the most likely candidate gene at the locus. The tetraspa-
nin gene family encodes a series of glycosylated, 4-pass 
transmembrane proteins that feature 1 short and 1 long 
extracellular loop. Through multiple protein–protein inter-
actions involving other tetraspanins, integrins, signalling 
receptors, immunoglobulins and proteolytic enzymes, tet-
raspanins are instrumental in forming membrane micro-
domains with specific functions (Seipold and Saftig 2016). 
Mutations in PRPH2 (also known as TSPAN22 or RDS) 
and in ROM1 (also known as TSPAN23), which function 
together in stabilising the structure of photoreceptor outer 
segment discs, can cause retinitis pigmentosa (Kajiwara 
et al. 1994), while mutations in TSPAN12 can cause famil-
ial exudative vitreo-retinopathy type 5 (EVR5) (Poulter 
et al. 2010; Nikopoulos et al. 2010). Tetraspanin-10, which 
was first detected in a cDNA library from retinal pigment 
epithelium/choroid and given the name oculospanin (Wis-
tow et al. 2002), is part of the TSpanC8 subfamily (tetras-
panins with 8 cysteine residues in their large extracellular 
domain). TSpanC8 tetraspanins are implicated in the traf-
ficking of ADAM10 and cleavage of Notch, prior to its 
further processing by γ-secretase (Dornier et al. 2012). 
Targets of γ-secretase include (Wakabayashi et al. 2009) 
APP (amyloid precursor protein) and APLP-2 (amyloid 
beta precursor-like protein-2); the latter protein has been 
linked to myopia development through an interaction with 
time spent reading (Tkatchenko et al. 2015). The precise 
roles of tetraspanin-10 in neuronal tissues such as cranial 
nerves, retina and brain are not clear. Notably, the cysteine 
at position 177 of TSPAN10 affected by rs6420484 is not 
one of the 8 cysteines in its large extracellular loop, sug-
gesting that the SNP would not directly impair cleavage 
activity. The NPLOC4 gene encodes NPL4 homolog, ubiq-
uitin recognition factor. Little is known of the physiologi-
cal role of this protein, although its predicted functions 
include metal ion binding, protein binding, and ubiquitin 
binding, suggesting a role in ubiquitin-dependent catabo-
lism or endoplasmic reticulum/Golgi organisation. PDE6G 
codes for the (inhibitory) γ-subunit of cGMP-phosphodi-
esterase. As well as its well-known role in rod phototrans-
duction, this protein regulates MAPK (mitogen-activated 
protein kinase) signalling via GRK2 (G protein-coupled 
receptor kinase 2) (Wan et al. 2003). Mutations in PDE6G 
are a rare cause of autosomal recessive retinitis pigmen-
tosa (Dvir et al. 2010; Tsang et al. 1996).
In summary, a genome-wide association study for self-
reported strabismus in a large sample of unrelated European 
individuals identified a single, novel locus associated with 
this trait.
The association with strabismus was replicated in a sam-
ple of 7-year-old children with clinician-diagnosed strabis-
mus (OR = 1.8, p = 0.009). The strongest candidate func-
tional variants were a non-synonymous SNP, rs6420484, 
which introduces a C177Y substitution in the TSPAN10 
gene, and a TSPAN10-frameshift-inducing 4-bp indel, 
rs397693108. These variants were associated with reduced 
TSPAN10 gene expression in brain tissues, although such 
eQTL effects were also observed for the adjacent genes 
PDE6G and ARL16, suggesting that the risk of strabismus 
could be mediated through any one or more of these genes. 
The identification of a common polymorphism conferring 
susceptibility to strabismus, opens a new avenue for research 
to understand the causal mechanisms responsible.
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